For those of you who read the 8K today regarding the case
For those of you who read the 8K today regarding the case that was just closed below are two critical points to take away from it
1. "The Stipulation gives the Company the right, at its option, to set a reasonable floor price before the beginning of each trading day, representing the minimum price at which ECVI may sell Shares during that day. In the event a floor price has not been provided for a trading day, the most recently provided floor price will apply to that trading day"
This means XUN will control at what price shares can be sold into the market. This is not anywhere near the toxic debt of the likes of Asher or others who decide when, where and how much of the debt they can dumb into the mix at any point in time.
2. "At no time will Shares be issued to ECVI in an amount which will result in ECVI owning more than 9.99% of the Company ’ s issued and outstanding shares and as such, the Shares to be issued to ECVI are expected to be issued in tranches."
Tranches are partial lots of the whole number of shares that they company will eventually have to provide to ECVI. This in turn will help prevent ECVI from shorting the stock at any point in time.
These two items, XUN controlling the floor price and the number of shares released each time will help XUN limit shorting and mass dilution into the market.
For ECVI to accept this they must be very, very comfortable that XUN's PPS is going to go up, and up big time in the near term future.
Xun Energy Inc. (XNRG) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Houston's Innovation Scene Expands The ground's barely settled and already Rice University is shaking up the scene in Houston’s Ion District with the Arc. At nearly 200,000 square feet, this powerhouse is set to bridge the gap between research, industry, and entrepreneurs, pushing ideas from discovery to reality. A Groundbreaking Investment For anyone with half an idea...
Continue Reading
A Statistical Leap in Liver Fat Reduction MetaVia's latest Phase 1 data for DA-1726 makes a splash with a 68% reduction in liver fat, and I can't say I'm not intrigued. When results like these hit the table, it gives those of us who keep a close watch on the biotechnology world reason to pause. The reduction in liver fat isn't just another number; it's a chart-buster...
Continue Reading
Hospital Hiring Gets a Tech Boost In the bustling world of healthcare recruitment, it's like trudging through quicksand with a time bomb strapped to your back. That's where PSG Global Solutions sauntered into the Las Vegas spotlight with Anna AI, their generative AI marvel that just snagged the Innovative Technology designation from Vizient. This ain’t your...
Continue Reading
Breaking Ground in the Fight Against Huntington's The latest shuffle in the relentless pursuit of medical breakthroughs sees Skyhawk Therapeutics rolling their dice in the fight against Huntington's disease (HD) with the U.S. launch of their pivotal FALCON-HD study. HD is a treacherous, progressive disorder that’s been stealing time from patients for far too long. It's...
Continue Reading
Shakeup at the North Texas Job Fair Slinging insurance ain't everyone's dream gig, but some folks find their calling where money meets meaning. The North Texas Job Fair, already known for its heavy foot traffic, saw a unique player strutting their stuff this year—Empower Brokerage. This family-owned insurance agency wasn't just slinging corporate pitch; they offered a...
Continue Reading
Shaking Up the Software Game November 2026 is set to be a standout period for tech aficionados, as Port, the AI Software Factory platform, rolls out the red carpet for PortCon, the inaugural AI Software Factory Summit, in San Francisco. This summit is no small fry in the industry kettle—it's going to be a rendezvous where tech heavyweights, including the likes of Uber,...
Continue Reading
An Award to Nod At: ASTHO's Public Health Triumph The world of public health isn't generally where you'd find shiny accolades flying around, but when they do, it's worth taking notice. Recently, ASTHO’s podcast, the Public Health Review Morning Edition, snagged a Bronze Anthem Award. Sure, it isn't the gold trophy, but in this high-stakes arena, any medal's a feat! More...
Continue Reading
Trading Rust: Resharpening Carbide Cutting Tools Alright, picture this: you've got a toolbox full of worn carbide tools, each looking like they've seen better days. You might toss 'em out and grab some new ones, right? But hold on! Carl Ciesla, a cutting tool vet from Sanborn, NY, is talking all about how resharpening could be your ticket to saving a heap of cash and...
Continue Reading
Revolutionizing Apparel Design with AI If you've ever wondered how tech can make an impact on the fashion world, Koozee's latest update provides an eye-opening look. This isn't about following trends—it's about setting them, and Koozee’s making a bold move with its newest platform enhancements. Introducing Freeform Canvas Koozee has launched the Freeform Canvas, a...
Continue Reading
Significant Boosts in Mesothelioma Support November's chill didn't slow down major support for mesothelioma initiatives. On October 22, 2026, during the grand setting of the Foundation's 2026 International Symposium on Malignant Mesothelioma in The Woodlands, Texas, MesoCare.org and Danziger & De Llano, LLP stepped up big time. Their philanthropic moves weren't just about...
Continue Reading
Top 5 Most Recently Viewed Articles
BluSky AI Inc. Announces Transition to OTCID Designation BluSky AI Inc. (OTC: BSAI), a trailblazer in the realm of modular AI data center infrastructure, is excited to share a pivotal development: the company will move to the OTCID platform effective July 1, 2025. This change signifies BluSky AI's adherence to higher reporting and compliance standards, which is essential...
Continue Reading
AST SpaceMobile Stock Price Decline AST SpaceMobile Inc. (NASDAQ: ASTS) has recently encountered a notable decline in its share prices. This shift has sparked interest among investors and analysts, raising questions about the factors contributing to this situation. Pricing of Convertible Senior Notes The primary catalyst for this downturn was the company’s announcement...
Continue Reading
C3.ai Faces Scrutiny Over Recent Financial Performance C3.ai, Inc. is currently under the microscope as investors express growing concerns following its latest financial announcement. The circumstances surrounding these results have led to inquiries regarding possible securities fraud and improper business practices within the company. Investigation by Pomerantz Law Firm...
Continue Reading
Voranigo® Recognized with Multiple Prix Galien Awards Servier's Voranigo® (vorasidenib) has recently achieved remarkable recognition by winning the prestigious Prix Galien Awards in various regions. This acknowledgment serves as a testament to the significant strides made by Voranigo® in benefiting patients diagnosed with glioma. The awards include the Prix Galien USA,...
Continue Reading
Telesat's Financial Overview Today, Telesat, recognized as one of the largest satellite operators in the world, disclosed its financial results, shedding light on its performance for the recent fiscal year ended December 31, 2024. The company operates under the ticker symbols NASDAQ and TSX: TSAT, which denote its presence on two significant stock exchanges. Financial...
Continue Reading